Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • A study comparing Rinatabart Sesutecan to other treatments in patients with endometrial cancer who have previously received platinum-based chemotherapy and PD-L1 therapy

    Recruiting

    3 1 1 1
    Belgium Denmark Finland France Germany Greece +5
  • Study to evaluate the safety and effectiveness of inhaled nintedanib in patients with idiopathic pulmonary fibrosis

    Recruiting

    2 1
    Germany Ireland Italy Spain
  • Comparing pivmecillinam and gentamicin with standard treatments for hospitalized adults with complicated urinary tract infections

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Denmark
  • A study to evaluate the effectiveness of barzolvolimab in participants with cold urticaria and symptomatic dermographism

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Lithuania Poland Spain
  • A study to evaluate the safety and effectiveness of HLX43 in patients with advanced non-small cell lung cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy Poland Romania Spain
  • A study to evaluate the effects of N-Acetyl-L-Leucine in patients with CACNA1A disorders

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Germany Greece Italy
  • Study of Grass Pollen Extract and Olive Pollen Extract for Patients with Hay Fever and Asthma caused by Grass and Olive Pollen Allergies

    Recruiting

    3 1
    Portugal Spain
  • Study of the efficacy and safety of depigmented polymerized grass pollen extracts for patients with allergic rhinitis and controlled asthma.

    Recruiting

    3 1
    Investigated Diseases:
    Portugal Spain
  • A study to evaluate the effectiveness and safety of LAD603 in adults with severe to very severe alopecia areata

    Recruiting

    2 1
    Investigated Diseases:
    Bulgaria Germany Poland Romania Spain
  • A study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer

    Recruiting

    3 1 1
    Czechia France Germany Greece Hungary Italy +2